“Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return, according to trial results published* in The Lancet (link is external) today (Wednesday).
“The Cancer Research UK-funded IMPORT LOW trial** revealed that five years after treatment, almost all patients were disease free.***
“The researchers at 30 radiotherapy centres across the UK, led by The Institute of Cancer Research, London(link is external), and the Cancer Research UK Cambridge Centre(link is external), studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of coming back.”
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to use our ASK Cancer Commons service.